Correction to: PharmacoEconomics - Open 10.1007/s41669-019-0124-5
Multiple errors have been identified in the article including in the main findings.
For example, two sentences in the abstract, Results, which read:
“Variable costs (HD: US$172, 359.15; PD: US$20, 488.79) were found to be the biggest cost drivers for both treatment modalities. The annual cost of HD per patient (US$205, 681.40) was higher than PD (US$25, 282.00 per patient), even though the difference was not statistically significant (p = 0.175)”.
Should have read:
“Fixed costs were the principal cost driver for HD ($16,231.45) while variable costs were the principal cost driver for PD (US$20,488.79). The annual cost of HD per patient (US$31,993.12) was higher than PD (US$25,282.00 per patient), even though the difference was not statistically significant (p = 0.816)”.
Errors were also identified in the following locations:
Section “3 Results”
Section “4 Discussion”
Table 1
Table 3
Figure 2
Table 6
Section “5 Conclusion”
The article has now been updated to correct the errors.
Contributor Information
Letlhogonolo Makhele, Email: makhele.nolo@gmail.com.
Moliehi Matlala, Email: moliehi.matlala@smu.ac.za.
Mncengeli Sibanda, Email: mncengelis@gmail.com.
Antony P. Martin, Email: a.p.martin@liverpool.ac.uk, Email: antony.martin@hcdeconomics.com
Brian Godman, Phone: 0141 548 3825, Phone: + 46 8 58581068, Email: Brian.Godman@strath.ac.uk, Email: Brian.Godman@ki.se.